• 1
    Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin's disease. Brain 1958; 81: 93111.
  • 2
    Cavanagh JB, Greenbaum D, Marshall AH, Rubinstein LJ. Cerebral demyelination associated with disorders of the reticuloendothelial system. Lancet 1959; 2: 5249.
  • 3
    Richardson EP Jr. Progressive multifocal leukoencephalopathy. N Engl J Med 1961; 265: 81523.
  • 4
    Zurhein GM, Chou SM. Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965; 148: 14779.
  • 5
    Silverman L, Rubinstein LJ. Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropathol 1965; 5: 21524.
  • 6
    Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 125760.
  • 7
    Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinstein LJ, et al. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 1972; 286: 38590.
  • 8
    Berger JR, Koralnik IJ. Progressive multifocal leukoencephalopathy and natalizumab: unforeseen consequences. N Engl J Med 2005; 353: 4146.
  • 9
    Berger JR, Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 2006; 28: 299305.
  • 10
    Bennett JL. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis. Neurol Res 2006; 28: 2918.
  • 11
    Vandecasteele SJ, Maes B, Claes K, Sciot R, Vanrenterghem Y. High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 2005; 20: 12467.
  • 12
    White RP, Abraham S, Singhal S, Manji H, Clarke CR. Progressive multifocal leucoencephalopathy isolated to the posterior fossa in a patient with systemic lupus erythematosus [letter]. Rheumatology (Oxford) 2002; 41: 8267.
  • 13
    Ahmed F, Aziz T, Kaufman LD. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. J Rheumatol 1999; 26: 160912.
  • 14
    Kinoshita M, Iwana K, Shinoura H, Aotsuka S, Sumiya M. Progressive multifocal leukoencephalopathy resembling central nervous system systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16: 3135.
  • 15
    Riskind PN, Richardson EP. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 20-1995: a 66-year-old man with a history of rheumatoid arthritis treated with adrenocorticosteroids, with the development of aphasia and right-sided weakness. N Engl J Med 1995; 332: 177380.
  • 16
    Itoh K, Kano T, Nagashio C, Mimori A, Kinoshita M, Sumiya M. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 10202.
  • 17
    Kaye BR, Neuwelt M, London SS, DeArmond SJ. Central nervous system systemic lupus erythematosus mimicking progressive multifocal leukoencephalopathy. Ann Rheum Dis 1992; 51: 11526.
  • 18
    Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993; 33: 40711.
  • 19
    Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306: 13803.